What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Neurotransmitter
His primary areas of investigation include Adenosine, Neuroscience, Internal medicine, Endocrinology and Adenosine A2A receptor.
His biological study spans a wide range of topics, including Extracellular, Adenosine A1 receptor, Adenosine receptor, Neurotransmission and Pharmacology.
His Adenosine A1 receptor research is multidisciplinary, incorporating perspectives in Adenosine A3 receptor, Biophysics, Purinergic signalling, Adenosine deaminase and Receptor antagonist.
His studies in Neuroscience integrate themes in fields like Synaptic plasticity, Receptor, Glutamatergic and Glutamate receptor.
His research integrates issues of Agonist, Antagonist and Microglia in his study of Endocrinology.
His Adenosine A2A receptor research integrates issues from Alzheimer's disease, Forebrain, Dopamine receptor D2 and Chronic stress.
His most cited work include:
- Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors (523 citations)
- Adenosine and Brain Function (519 citations)
- Presynaptic Control of Striatal Glutamatergic Neurotransmission by Adenosine A1–A2A Receptor Heteromers (465 citations)
What are the main themes of his work throughout his whole career to date?
Neuroscience, Internal medicine, Endocrinology, Adenosine and Adenosine A2A receptor are his primary areas of study.
His Neuroscience research includes themes of Synaptic plasticity, Receptor and Long-term potentiation.
His Endocrinology research is multidisciplinary, relying on both Agonist, CGS-21680, Adenosine receptor antagonist and Antagonist.
The various areas that Rodrigo A. Cunha examines in his Adenosine study include Adenosine A1 receptor, Purinergic signalling, Adenosine receptor and Receptor antagonist.
His research in Adenosine A1 receptor intersects with topics in Extracellular, Adenosine A3 receptor and Adenosine deaminase.
His studies in Adenosine A2A receptor integrate themes in fields like SCH-58261, Glutamate receptor, Neuroprotection, Pharmacology and Dopamine.
He most often published in these fields:
- Neuroscience (39.16%)
- Internal medicine (38.55%)
- Endocrinology (37.65%)
What were the highlights of his more recent work (between 2017-2021)?
- Neuroscience (39.16%)
- Adenosine A2A receptor (29.52%)
- Adenosine (31.63%)
In recent papers he was focusing on the following fields of study:
Rodrigo A. Cunha spends much of his time researching Neuroscience, Adenosine A2A receptor, Adenosine, Internal medicine and Endocrinology.
His work carried out in the field of Neuroscience brings together such families of science as Synaptic plasticity, Long-term potentiation and Neurotransmission.
His work deals with themes such as Neurodegeneration, Microglia, Neuroprotection, Dopamine and Knockout mouse, which intersect with Adenosine A2A receptor.
His Adenosine research integrates issues from Receptor, Adenosine A1 receptor, Adenosine receptor and Cell biology.
In his study, Neuroplasticity, Water maze and Impulsivity is inextricably linked to Attention deficit hyperactivity disorder, which falls within the broad field of Internal medicine.
His Open field study in the realm of Endocrinology connects with subjects such as Binge drinking.
Between 2017 and 2021, his most popular works were:
- Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors (59 citations)
- Neuronal Adenosine A2A Receptors Are Critical Mediators of Neurodegeneration Triggered by Convulsions. (30 citations)
- The belated US FDA approval of the adenosine A 2A receptor antagonist istradefylline for treatment of Parkinson’s disease (29 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Internal medicine
- Neurotransmitter
His primary areas of investigation include Neuroscience, Adenosine A2A receptor, Long-term potentiation, Adenosine and Hippocampal formation.
His Neuroscience study combines topics in areas such as Excitotoxicity and Neurodegeneration.
His Adenosine A2A receptor research includes elements of Glutamate receptor, Adenosine A1 receptor, Cognition, Microglia and Neuroprotection.
Rodrigo A. Cunha combines subjects such as Synaptic plasticity and Hippocampus with his study of Long-term potentiation.
His Hippocampus study falls within the topics of Endocrinology and Internal medicine.
His Adenosine research includes themes of Receptor, Pharmacology and Adenosine receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
